FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2361111000001108: Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1891401000001119 Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1891421000001114 Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is a Thioridazine 25mg tablets 500 tablet true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is pack of Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has active ingredient Thioridazine hydrochloride false Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has AMP Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has specific active ingredient Thioridazine hydrochloride true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start